Showing results (91-100 of 324) with videos related to

Sort By:
Pageof 33
Clinical Lung Cancer|January 8, 2013
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancerWei-Yu Liao, Jin-Hsin Chen, Muzo Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2011
Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexedChung-Yu Chen, Yih-Leong Chang, Jin-Yuan Shih, et al.
The European Respiratory Journal|September 29, 2012
Survival of lung adenocarcinoma patients with malignant pleural effusionShang-Gin Wu, Chong-Jen Yu, Meng-Feng Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 6, 2024
Hope and its relationship with treatment/ physical related factors in lung cancer patients receiving immunotherapyChih-Chien Hsu, Yun-Hsiang Lee, Min-Ru Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2010
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutationsShang-Gin Wu, Chih-Hsin Yang, Chong-Jen Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment responseJenn-Yu Wu, Shang-Gin Wu, Chih-Hsin Yang, et al.
Frontiers in Oncology|May 16, 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief ReportJames Chih-Hsin Yang, Martin Schuler, Sanjay Popat, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 19, 2010
Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controlsLukas Jyuhn-Hsiarn Lee, Chih-Wen Chung, Yu-Yin Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)James Chih-Hsin Yang, Yi-Long Wu, Valorie Chan, et al.
JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.
Pageof 33